A study identifies motor delay and hypotonia as key predictors of genetic diagnoses, aiding clinicians in neurodevelopmental care and genetic testing decisions.
Meta Title: AstraZeneca Plc Patent: Improved AAV Vector Production with Specific Plasmid Sequence
Share this article According to GlobalData’s company profile on AstraZeneca, Personalized cancer vaccines was a key innovation area identified from patents. AstraZeneca‘s grant share as